Find Dorzagliatin manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

API

0

FDF

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 1191995-00-2, Hms5552, Sinogliatin, Ro5305552, Hms-5552, Dorzagliatin [inn]
Molecular Formula
C22H27ClN4O5
Molecular Weight
462.9  g/mol
InChI Key
HMUMWSORCUWQJO-QAPCUYQASA-N
FDA UNII
X59W6980E8

Dorzagliatin
Dorzagliatin is under investigation in clinical trial NCT03173391 (Long-term Efficacy and Safety of HMS5552 in T2DM).
1 2D Structure

Dorzagliatin

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(2S)-2-[3-(2-chlorophenoxy)-5-oxo-2H-pyrrol-1-yl]-N-[1-[(2R)-2,3-dihydroxypropyl]pyrazol-3-yl]-4-methylpentanamide
2.1.2 InChI
InChI=1S/C22H27ClN4O5/c1-14(2)9-18(22(31)24-20-7-8-26(25-20)11-15(29)13-28)27-12-16(10-21(27)30)32-19-6-4-3-5-17(19)23/h3-8,10,14-15,18,28-29H,9,11-13H2,1-2H3,(H,24,25,31)/t15-,18+/m1/s1
2.1.3 InChI Key
HMUMWSORCUWQJO-QAPCUYQASA-N
2.1.4 Canonical SMILES
CC(C)CC(C(=O)NC1=NN(C=C1)CC(CO)O)N2CC(=CC2=O)OC3=CC=CC=C3Cl
2.1.5 Isomeric SMILES
CC(C)C[C@@H](C(=O)NC1=NN(C=C1)C[C@H](CO)O)N2CC(=CC2=O)OC3=CC=CC=C3Cl
2.2 Other Identifiers
2.2.1 UNII
X59W6980E8
2.3 Synonyms
2.3.1 MeSH Synonyms

1. (2s)-2-(4-(2-chlorophenoxy)-2-oxo-2,5-dihydro-1h-pyrrol-1-yl)-n-(1-((2r)-2,3-dihydroxypropyl)-1h-pyrazol-3-yl)-4-methylpentanamide

2. Hms5552

3. Sinogliatin

2.3.2 Depositor-Supplied Synonyms

1. 1191995-00-2

2. Hms5552

3. Sinogliatin

4. Ro5305552

5. Hms-5552

6. Dorzagliatin [inn]

7. Ro-5305552

8. X59w6980e8

9. Dorzagliatin (usan)

10. Dorzagliatin [usan]

11. (2s)-2-(4-(2-chlorophenoxy)-2-oxo-2,5-dihydro-1h-pyrrol-1-yl)-n-(1-((2r)-2,3-dihydroxypropyl)-1h-pyrazol-3-yl)-4-methylpentanamide

12. (2s)-2-[4-(2-chlorophenoxy)-2-oxo-2,5-dihydro-1h-pyrrol-1-yl]-n-{1-[(2r)-2,3-dihydroxypropyl]-1h-pyrazol-3-yl}-4-methylpentanamide

13. Dorzagliatin [usan:inn]

14. Dorzagliatin [who-dd]

15. Schembl1079619

16. Chembl4297508

17. Unii-x59w6980e8

18. Gtpl12124

19. Hms5552hms5552

20. Glxc-25388

21. Bcp20539

22. Ex-a4478

23. Mfcd22376579

24. S6921

25. Hms5552;ro5305552;sinogliatin

26. Db15123

27. Bd167920

28. Bs-14600

29. Hy-109030

30. Cs-0030544

31. D11342

32. D83693

33. (2s)-2-[3-(2-chlorophenoxy)-5-oxo-2h-pyrrol-1-yl]-n-[1-[(2r)-2,3-dihydroxypropyl]pyrazol-3-yl]-4-methylpentanamide

34. (s)-2-(4-(2-chlorophenoxy)-2-oxo-2,5-dihydro-1h-pyrrol-1-yl)-n-(1-((r)-2,3-dihydroxypropyl)-1h-pyrazol-3-yl)-4-methylpentanamide

35. (s)-2-[4-(2-chloro-phenoxy)-2-oxo-2,5-dihydro-pyrrol-1-yl]-4-methyl-pentanoic Acid [1-((r)-2,3-dihydroxy-propyl)-1h-pyrazol-3-yl]-amide

36. 1h-pyrrole-1-acetamide, 4-(2-chlorophenoxy)-n-(1-((2r)-2,3-dihydroxypropyl)-1h-pyrazol-3-yl)-2,5-dihydro-.alpha.-(2-methylpropyl)-2-oxo-, (.alpha.s)-

37. 1h-pyrrole-1-acetamide, 4-(2-chlorophenoxy)-n-(1-((2r)-2,3-dihydroxypropyl)-1h-pyrazol-3-yl)-2,5-dihydro-alpha-(2-methylpropyl)-2-oxo-, (alphas)-

2.4 Create Date
2012-08-19
3 Chemical and Physical Properties
Molecular Weight 462.9 g/mol
Molecular Formula C22H27ClN4O5
XLogP31.6
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count6
Rotatable Bond Count10
Exact Mass462.1669977 g/mol
Monoisotopic Mass462.1669977 g/mol
Topological Polar Surface Area117 Ų
Heavy Atom Count32
Formal Charge0
Complexity691
Isotope Atom Count0
Defined Atom Stereocenter Count2
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty